Viveve Medical Q3 EPS $(0.59) Beats $(0.66) Estimate, Sales $1.68M Miss $1.70M Estimate

Author: Benzinga Newsdesk | November 10, 2022 05:17pm
Viveve Medical (NASDAQ:VIVE) reported quarterly losses of $(0.59) per share which beat the analyst consensus estimate of $(0.66) by 10.61 percent. This is a 11.94 percent increase over losses of $(0.67) per share from the same period last year. The company reported quarterly sales of $1.68 million which missed the analyst consensus estimate of $1.70 million by 0.94 percent. This is a 4.21 percent increase over sales of $1.62 million the same period last year.

Posted In: VIVE